BIOS — Bioservo Technologies AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Bioservo Technologies AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	SAS	SAS	SAS	SAS	SAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	25.6	56.9	52.6	51.5	25
Net Total Accounts Receivable
Net Total Receivables	3.76	5.8	4.57	2.81	6.49
Total Inventory
Prepaid Expenses
Total Current Assets	34.2	68	60.2	65.5	46.4
Net Property, Plant And Equipment	0.621	0.504	0.355	0.205	0.186
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	50.2	81.3	70.6	73.5	52.5
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	10.1	6	7.99	10.6	14.1
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	10.1	6	8.3	10.8	15.1
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	40.1	75.3	62.3	62.8	37.5
Total Liabilities & Shareholders' Equity	50.2	81.3	70.6	73.5	52.5
Total Common Shares Outstanding